Literature DB >> 3279987

Malignant hyperthermia: biochemical aspects of the acute episode.

J J Heffron1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3279987     DOI： 10.1093/bja/60.3.274

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

2.  Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.

Authors:  S J Healy; J J Heffron; M Lehane; D G Bradley; K Johnson; T V McCarthy
Journal:  BMJ       Date:  1991-11-16

3.  Neuroleptic malignant syndrome without the use of neuroleptics.

Authors:  D Heyland; M Sauvé
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

4.  Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.

Authors:  I Moroni; E F Gonano; G P Comi; V Tegazzin; A Prelle; A Bordoni; N Bresolin; G Scarlato
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

5.  Effects of MDMA on blood glucose levels and brain glucose metabolism.

Authors:  M L Soto-Montenegro; J J Vaquero; C Arango; G Ricaurte; P García-Barreno; M Desco
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-12       Impact factor: 10.057

6.  Associations of biochemical changes and maternal traits with mutation 1843 (C>T) in the RYR1 gene as a common cause for porcine stress syndrome.

Authors:  Z T Popovski; B Tanaskovska; E Miskoska-Milevska; S Andonov; S Domazetovska
Journal:  Balkan J Med Genet       Date:  2017-03-08       Impact factor: 0.519

7.  Malignant hyperthermia.

Authors:  Dong-Chan Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.